journal article·2022-07-27

Tailorable 3DP Flexible Scaffolds with Porosification of Filaments Facilitate Cell Ingrowth and Biomineralized Deposition

Peiyang Gu, Yang Xu, Quanying Liu, Yuxiang Wang, Zhulian Li, Manyu Chen, Ruiqi Mao, Jie Liang, Xingdong Zhang, Yujiang Fan, Yong Sun

ACS Applied Materials & Interfaces· Volume 14· Issue 29
Publisher page

Abstract

Facilitating cell ingrowth and biomineralized deposition inside filaments of 3DP scaffolds are an ideal bone repair strategy. Here, 3D printed PLGA/HA scaffolds with hydroxyapatite content of 50% (P5H5) and 70% (P3H7) were prepared by optimizing 3D printing inks, which exhibited good tailorability and foldability to meet clinical maneuverability. The supercritical CO2 foaming technology further endowed the filaments of P5H5 with a richer interconnected pore structure (P5H5-C). The finite element and computational fluid dynamics simulation analysis indicated that the porosification could effectively reduce the stress concentration at the filament junction and improved the overall permeability of the scaffold. The results of in vitro experiments confirmed that P5H5-C promoted the adsorption of proteins on the surface and inside of filaments, accelerated the release of Ca and P ions, and significantly upregulated osteogenesis (Col I, ALP, and OPN)- and angiogenesis (VEGF)-related gene expression. Subcutaneous ectopic osteogenesis experiments in nude mice further verified that P5H5-C facilitated cell growth inside filaments and biomineralized deposition, as well as significantly upregulated the expression of osteogenesis- and angiogenesis-related genes (Col I, ALP, OCN, and VEGF) and protein secretion (ALP, RUNX2, and VEGF). The porosification of filaments by supercritical CO2 foaming provided a new strategy for accelerating osteogenesis of 3DP implants.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Polymer Foaming and Composites · Bone Tissue Engineering Materials · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National Engineering Research Center for Biomaterials, Sichuan University, 29# Wangjiang Road, Chengdu 610064, China

College of Biomedical Engineering, Sichuan University, 29# Wangjiang Road, Chengdu 610064, China

Sichuan Testing Center for Biomaterials and Medical Devices, Sichuan University, 29# Wangjiang Road, Chengdu 610064, China

Funding

Sichuan University · National Natural Science Foundation of China · National Key R&D Plan of China

References (60)

Show source-provided references
1. 10.1002/adfm.20190327910.1002/adfm.201903279 ↗
2. 10.1126/sciadv.aaz672510.1126/sciadv.aaz6725 ↗
3. 10.1038/nmat471910.1038/nmat4719 ↗
4. 10.1016/j.actbio.2020.11.03210.1016/j.actbio.2020.11.032 ↗
5. 10.1002/advs.20170040110.1002/advs.201700401 ↗
6. 10.1016/j.bioactmat.2020.09.00310.1016/j.bioactmat.2020.09.003 ↗
7. 10.1021/acsnano.9b0472310.1021/acsnano.9b04723 ↗
8. 10.1021/acsami.9b2310010.1021/acsami.9b23100 ↗
9. 10.1016/j.bioactmat.2020.11.01910.1016/j.bioactmat.2020.11.019 ↗
10. 10.1039/d0nr06297a10.1039/d0nr06297a ↗
11. 10.1177/088532821663632010.1177/0885328216636320 ↗
12. 10.1016/j.biomaterials.2004.02.05210.1016/j.biomaterials.2004.02.052 ↗
13. 10.1016/j.mattod.2018.07.01610.1016/j.mattod.2018.07.016 ↗
14. 10.1016/j.cclet.2021.11.09010.1016/j.cclet.2021.11.090 ↗
15. 10.1016/j.biomaterials.2019.01.01310.1016/j.biomaterials.2019.01.013 ↗
16. 10.1016/j.bioactmat.2020.01.00410.1016/j.bioactmat.2020.01.004 ↗
17. 10.1002/mabi.20210044210.1002/mabi.202100442 ↗
18. 10.1016/j.actbio.2021.03.06710.1016/j.actbio.2021.03.067 ↗
19. 10.1088/1758-5090/8/1/01501110.1088/1758-5090/8/1/015011 ↗
20. 10.1007/s40684-019-00067-810.1007/s40684-019-00067-8 ↗
21. 10.1016/j.mattod.2022.01.00110.1016/j.mattod.2022.01.001 ↗
22. 10.1002/adfm.20200018710.1002/adfm.202000187 ↗
23. 10.1016/j.copbio.2021.12.00210.1016/j.copbio.2021.12.002 ↗
24. 10.1002/adma.20210885510.1002/adma.202108855 ↗
25. 10.1039/D0TA04181E10.1039/D0TA04181E ↗
26. 10.1126/scitranslmed.aaf770410.1126/scitranslmed.aaf7704 ↗
27. 10.1002/adfm.20190140710.1002/adfm.201901407 ↗
28. 10.1002/med.2167210.1002/med.21672 ↗
29. 10.1016/j.addma.2020.10161610.1016/j.addma.2020.101616 ↗
30. 10.1016/j.biomaterials.2017.10.02510.1016/j.biomaterials.2017.10.025 ↗
31. 10.1016/j.addma.2021.10198810.1016/j.addma.2021.101988 ↗
32. 10.1016/j.cclet.2020.12.00110.1016/j.cclet.2020.12.001 ↗
33. 10.1016/j.msec.2017.12.01610.1016/j.msec.2017.12.016 ↗
34. 10.1021/acsami.0c1520510.1021/acsami.0c15205 ↗
35. 10.1016/j.msec.2020.11180110.1016/j.msec.2020.111801 ↗
36. 10.1016/j.biomaterials.2016.08.00410.1016/j.biomaterials.2016.08.004 ↗
37. 10.1016/j.msec.2009.09.00210.1016/j.msec.2009.09.002 ↗
38. 10.1002/adem.20180136210.1002/adem.201801362 ↗
39. 10.1016/j.matlet.2014.05.19410.1016/j.matlet.2014.05.194 ↗
40. 10.1016/j.bioactmat.2020.08.01610.1016/j.bioactmat.2020.08.016 ↗
41. 10.1021/acsbiomaterials.7b0030110.1021/acsbiomaterials.7b00301 ↗
42. 10.1016/j.apsusc.2018.04.05910.1016/j.apsusc.2018.04.059 ↗
43. 10.1016/j.actbio.2010.11.04310.1016/j.actbio.2010.11.043 ↗
44. 10.3390/pharmaceutics1211111810.3390/pharmaceutics12111118 ↗
45. 10.1038/srep2951010.1038/srep29510 ↗
46. 10.1016/j.supflu.2016.05.04310.1016/j.supflu.2016.05.043 ↗
47. 10.1021/ie030199z10.1021/ie030199z ↗
48. 10.1021/ie801948310.1021/ie8019483 ↗
49. 10.1016/j.actbio.2015.02.00310.1016/j.actbio.2015.02.003 ↗
50. 10.1016/j.ijengsci.2013.06.01310.1016/j.ijengsci.2013.06.013 ↗
51. 10.1016/S0142-9612(01)00002-310.1016/S0142-9612(01)00002-3 ↗
52. 10.1016/S0142-9612(03)00515-510.1016/S0142-9612(03)00515-5 ↗
53. 10.1038/s41578-020-0204-210.1038/s41578-020-0204-2 ↗
54. 10.1016/j.cclet.2021.10.07310.1016/j.cclet.2021.10.073 ↗
55. 10.1038/boneres.2017.5910.1038/boneres.2017.59 ↗
56. 10.1021/acsbiomaterials.1c0048310.1021/acsbiomaterials.1c00483 ↗
57. 10.1021/acsami.9b0428310.1021/acsami.9b04283 ↗
58. 10.1002/adfm.20180433510.1002/adfm.201804335 ↗
59. 10.1002/advs.20160005810.1002/advs.201600058 ↗
60. 10.1021/am500885v10.1021/am500885v ↗